Liquid biopsy in genitourinary cancers: circulating tumor DNA as a predictive biomarker for treatment selection and resistance monitoring

Alcides Chaux, Andrea Paola Britos Gómez

Open source

DOI
10.37349/etat.2026.1002407
Published
2026-10-19
Container
Exploration of Targeted Anti-tumor Therapy
Publisher
Open Exploration Publishing
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.37349/etat.2026.1002407,
  title = {Liquid biopsy in genitourinary cancers: circulating tumor DNA as a predictive biomarker for treatment selection and resistance monitoring},
  author = {Alcides Chaux and Andrea Paola Britos Gómez},
  year = {2026},
  journal = {Exploration of Targeted Anti-tumor Therapy},
  doi = {10.37349/etat.2026.1002407},
  url = {https://doi.org/10.37349/etat.2026.1002407}
}

RIS

TY  - JOUR
TI  - Liquid biopsy in genitourinary cancers: circulating tumor DNA as a predictive biomarker for treatment selection and resistance monitoring
AU  - Alcides Chaux
AU  - Andrea Paola Britos Gómez
PY  - 2026
JO  - Exploration of Targeted Anti-tumor Therapy
DO  - 10.37349/etat.2026.1002407
UR  - https://doi.org/10.37349/etat.2026.1002407
ER  - 

APA

Chaux, A., & Gómez, A. P. B. (2026). Liquid biopsy in genitourinary cancers: circulating tumor DNA as a predictive biomarker for treatment selection and resistance monitoring. Exploration of Targeted Anti-tumor Therapy. https://doi.org/10.37349/etat.2026.1002407

Source records